U.S., June 18 -- ClinicalTrials.gov registry received information related to the study (NCT07652684) titled 'Enteral Lipid Supplementation and Bronchoplumonary Dysplasia of Premature Infants' on May 30.
Brief Summary: The Impact of Omega-3 (DHA - Docosahexaenoic Acid) and Omega-6 (ARA - Arachidonic Acid) Supplementation on the Development of Bronchopulmonary Dysplasia in Extremely and Very Preterm Infants (24-29 weeks of gestational age).
Study Start Date: March 04, 2025
Study Type: INTERVENTIONAL
Condition:
Bronchopulmonary Dysplasia (BPD)
Intervention:
DIETARY_SUPPLEMENT: Enteral supplementation with ARA and DHA (in a 2:1 ratio) in addition to standard care and feeding
The intervention group will receive enteral supplementation co...